ロード中...
Hepatobiliary MR contrast agents are useful to diagnose hepatocellular carcinoma in patients with Budd-Chiari syndrome
BACKGROUND & AIMS: Hepatobiliary phase (HBP) images can discriminate between benign and malignant liver lesions, but it is unclear if this approach can be used in patients with Budd-Chiari syndrome (BCS). Thus, we aimed to assess the diagnostic utility of HBP images in patients with BCS. METHODS...
保存先:
| 出版年: | JHEP Rep |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7232085/ https://ncbi.nlm.nih.gov/pubmed/32435753 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhepr.2020.100097 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|